Cargando...

Rebound-Associated Vertebral Fractures Two Months After a Missed Dose of Denosumab

Introduction: Denosumab, an anti-resorptive medication approved for treatment of osteoporosis, increases bone mineral density and reduces fracture risk. Discontinuation of treatment is associated with bone turnover rebound and reduced bone mineral density. We report a case of a woman without prior h...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Endocr Soc
Main Authors: Caseja, Ahl Jeffrey, Abdullah, Najwa, Nakhle, Samer
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2021
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8090346/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.443
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!